Viewing Study NCT02916420


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-02-25 @ 4:50 AM
Study NCT ID: NCT02916420
Status: UNKNOWN
Last Update Posted: 2016-11-02
First Post: 2016-09-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SIM-135-Ⅲ
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators